Latest Hepatitis B in China Stories
DeepResearchReports.com adds “2015 Market Research Report on Global Hepatitis B Vaccine Industry” and “2015 Market Research Report on Global Hepatitis A Vaccine Industry” market research
- Proceeds to Support Phase II Clinical Development of SB 9200 Against Hepatitis B - MILFORD, Mass., Feb.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Small financial incentives, totaling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination.
XIANYANG, China, Jan. 15, 2014 /PRNewswire/ -- Biostar Pharmaceuticals, Inc.
Exciting new data presented today at the International Liver Congress™ 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for chronic hepatitis B virus (HBV) infection.
- An armed gangster.